Do we need to "hope" or rather can the dosage be revised following consultation with FDA?
I note the Marco suggested there will be an "update PARA_OA_002 Stage 1 dose selection 1H CY2023" which as also disclosed on slide 13.
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial
Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-42
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.8¢ |
Change
0.003(0.85%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 29.5¢ | $34.53K | 115.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 40539 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 56 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 40539 | 0.295 |
5 | 27379 | 0.290 |
3 | 52806 | 0.285 |
1 | 50000 | 0.280 |
1 | 5000 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 56 | 1 |
0.305 | 10000 | 1 |
0.310 | 80900 | 3 |
0.315 | 58007 | 5 |
0.320 | 120187 | 5 |
Last trade - 15.59pm 22/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |